| Issue Date | Title | Author(s) |
| 2023-03-28 | Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies. | Germon, ZP; Sillar, JR; Mannan, A; Duchatel, RJ; Staudt, D; Murray, HC; Findlay, IJ; Jackson, ER; McEwen, HP; Douglas, AM; McLachlan, T; Schjenken, JE; Skerrett-Byrne, DA; Huang, H; Melo-Braga, MN; Plank, MW; Alvaro, F; Chamberlain, J; De Iuliis, G; Aitken, RJ; Nixon, B; Wei, AH; Enjeti, AK; Huang, Y; Lock, RB; Larsen, MR; Lee, H; Vaghjiani, V; Cain, JE; de Bock, CE; Verrills, NM; Dun, MD |
| 2023-05-01 | Pleiotrophin drives a prometastatic immune niche in breast cancer. | Ganguly, D; Schmidt, MO; Coleman, M; Ngo, T-VC; Sorrelle, N; Dominguez, ATA; Murimwa, GZ; Toombs, JE; Lewis, C; Fang, YV; Valdes-Mora, F; Gallego-Ortega, D; Wellstein, A; Brekken, RA |
| 2023-04-01 | Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma. | Seneviratne, JA; Carter, DR; Mittra, R; Gifford, A; Kim, PY; Luo, J-S; Mayoh, C; Salib, A; Rahmanto, AS; Murray, J; Cheng, NC; Nagy, Z; Wang, Q; Kleynhans, A; Tan, O; Sutton, SK; Xue, C; Chung, SA; Zhang, Y; Sun, C; Zhang, L; Haber, M; Norris, MD; Fletcher, JI; Liu, T; Dilda, PJ; Hogg, PJ; Cheung, BB; Marshall, GM |
| 2023-10-25 | Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. | Zhai, L; Balachandran, A; Larkin, R; Seneviratne, JA; Chung, SA; Lalwani, A; Tsubota, S; Beck, D; Kadomatsu, K; Beckers, A; Durink, K; De Preter, K; Speleman, F; Haber, M; Norris, MD; Swarbrick, A; Cheung, BB; Marshall, GM; Carter, DR |
| 2024-07-11 | The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis. | Murray, JE; Valli, E; Milazzo, G; Mayoh, C; Gifford, AJ; Fletcher, JI; Xue, C; Jayatilleke, N; Salehzadeh, F; Gamble, LD; Rouaen, JRC; Carter, DR; Forgham, H; Sekyere, EO; Keating, J; Eden, G; Allan, S; Alfred, S; Kusuma, FK; Clark, A; Webber, H; Russell, AJ; de Weck, A; Kile, BT; Santulli, M; De Rosa, P; Fleuren, EDG; Gao, W; Wilkinson-White, L; Low, JKK; Mackay, JP; Marshall, GM; Hilton, DJ; Giorgi, FM; Koster, J; Perini, G; Haber, M; Norris, MD |
| 2024-04-30 | Ångstrom-scale gold particles loaded with alendronate via alpha-lipoic acid alleviate bone loss in osteoporotic mice. | Gao, W; Li, JJ; Shi, J; Lan, H; Guo, Y; Fu, D |
